Skip to main content
Adrestan 60 mg Hard Capsules
  • Trilostan
  • Valid
Authorised in these countries:
  • United Kingdom (Northern Ireland)

Product identification

Medicine name:
Adrestan 60 mg hard capsules
Adrestan 60 mg Hard Capsules
Active substance and strength:
  • Trilostan
    60.00
    milligram(s)
    /
    1.00
    Capsule
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QH02CA01
Authorisation number:
  • Vm 10434/4089
Product identification number:
  • 01c750e7-b4db-42c3-9b6d-a3feeadfb50c
Permanent identification number:
  • 600000049244

Product details

Pharmaceutical form:
  • Capsule, hard
Withdrawal period by route of administration:
  • Oral use
    • Dog

Availability

Package description:
  • Three PVC-PVdc/aluminium foil blister strips each containing 10 capsules.
Manufacturing sites for batch release:
  • Dales Pharmaceuticals Limited
  • EN- Genera Inc.
Source wholesaler:
This information is not available for this product.
Destination wholesaler:
This information is not available for this product.

Authorisation details

Authorisation status:
  • Valid
Authorisation procedure type:
  • Marketing Authorisation
Procedure number:
  • IE/V/0503/003
Date of authorisation status change:
Authorisation country:
  • United Kingdom (Northern Ireland)
Responsible authority:
  • VMD
Marketing authorisation holder:
  • Dechra Limited
Marketing authorisation issued:
Reference member state:
  • Ireland
Concerned member states:
  • Belgium
  • France
  • Italy
  • Netherlands
  • Portugal
  • Spain
  • United Kingdom (Northern Ireland)
Reference product identifier:
This information is not available for this product.
Source product identifier:
This information is not available for this product.

Additional information

To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet

Documents

First published:
Last updated:
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."